An initial pilot study of 15 patients has been undertaken.
Recruitment is ongoing.
Target enrollment of 200 patients is expected to be complete by 2004. SEE POST . Thrombolytic agent . Purpose To test the hypothesis that the administration of intra-arterial urokinase plus anticoagulants will reduce morbidity and mortality assessed at 6 months compared with the administration of anticoagulants alone. . Randomized, double-blind trial with a planned enrollment of 200 patients. .